Flutemetamol

CHEMBL579205 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

274.3 g/mol

LogP

3.8

Phase

4

This compound selectively binds to amyloid beta aggregates in brain tissue, used as part of PET imaging evaluation for Alzheimer's disease.

น้ำหนักโมเลกุล

274.3200 g/mol

LogP

3.80

TPSA

73.40 Å²

Lipinski RO5

ผ่าน

ด้านการรักษา

Alzheimer's Disease Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F

InChI

InChI=1S/C14H11FN2OS/c1-16-11-4-2-8(6-10(11)15)14-17-12-5-3-9(18)7-13(12)19-14/h2-7,16,18H,1H3

Molecular Formula

C14H11FN2OS

HBD / HBA

2 / 5

พันธะที่หมุนได้

2

อะตอมหนัก

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This compound selectively binds to amyloid beta aggregates in brain tissue, used as part of PET imaging evaluation for Alzheimer's disease.

Yes, Flutemetamol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL579205. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 10107393. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Flutemetamol บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C14H11FN2OS
คำพ้องความหมาย: 1

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.